BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37046096)

  • 1. The evolution of lung cancer and impact of subclonal selection in TRACERx.
    Frankell AM; Dietzen M; Al Bakir M; Lim EL; Karasaki T; Ward S; Veeriah S; Colliver E; Huebner A; Bunkum A; Hill MS; Grigoriadis K; Moore DA; Black JRM; Liu WK; Thol K; Pich O; Watkins TBK; Naceur-Lombardelli C; Cook DE; Salgado R; Wilson GA; Bailey C; Angelova M; Bentham R; Martínez-Ruiz C; Abbosh C; Nicholson AG; Le Quesne J; Biswas D; Rosenthal R; Puttick C; Hessey S; Lee C; Prymas P; Toncheva A; Smith J; Xing W; Nicod J; Price G; Kerr KM; Naidu B; Middleton G; Blyth KG; Fennell DA; Forster MD; Lee SM; Falzon M; Hewish M; Shackcloth MJ; Lim E; Benafif S; Russell P; Boleti E; Krebs MG; Lester JF; Papadatos-Pastos D; Ahmad T; Thakrar RM; Lawrence D; Navani N; Janes SM; Dive C; Blackhall FH; Summers Y; Cave J; Marafioti T; Herrero J; Quezada SA; Peggs KS; Schwarz RF; Van Loo P; Miedema DM; Birkbak NJ; Hiley CT; Hackshaw A; Zaccaria S; ; Jamal-Hanjani M; McGranahan N; Swanton C
    Nature; 2023 Apr; 616(7957):525-533. PubMed ID: 37046096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking the Evolution of Non-Small-Cell Lung Cancer.
    Jamal-Hanjani M; Wilson GA; McGranahan N; Birkbak NJ; Watkins TBK; Veeriah S; Shafi S; Johnson DH; Mitter R; Rosenthal R; Salm M; Horswell S; Escudero M; Matthews N; Rowan A; Chambers T; Moore DA; Turajlic S; Xu H; Lee SM; Forster MD; Ahmad T; Hiley CT; Abbosh C; Falzon M; Borg E; Marafioti T; Lawrence D; Hayward M; Kolvekar S; Panagiotopoulos N; Janes SM; Thakrar R; Ahmed A; Blackhall F; Summers Y; Shah R; Joseph L; Quinn AM; Crosbie PA; Naidu B; Middleton G; Langman G; Trotter S; Nicolson M; Remmen H; Kerr K; Chetty M; Gomersall L; Fennell DA; Nakas A; Rathinam S; Anand G; Khan S; Russell P; Ezhil V; Ismail B; Irvin-Sellers M; Prakash V; Lester JF; Kornaszewska M; Attanoos R; Adams H; Davies H; Dentro S; Taniere P; O'Sullivan B; Lowe HL; Hartley JA; Iles N; Bell H; Ngai Y; Shaw JA; Herrero J; Szallasi Z; Schwarz RF; Stewart A; Quezada SA; Le Quesne J; Van Loo P; Dive C; Hackshaw A; Swanton C;
    N Engl J Med; 2017 Jun; 376(22):2109-2121. PubMed ID: 28445112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution.
    Rodriguez EF; De Marchi F; Lokhandwala PM; Belchis D; Xian R; Gocke CD; Eshleman JR; Illei P; Li MT
    Cancer Med; 2020 Jun; 9(12):4386-4394. PubMed ID: 32333643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland.
    Grosse A; Grosse C; Rechsteiner M; Soltermann A
    Diagn Pathol; 2019 Feb; 14(1):18. PubMed ID: 30744664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors.
    Bjaanæs MM; Nilsen G; Halvorsen AR; Russnes HG; Solberg S; Jørgensen L; Brustugun OT; Lingjærde OC; Helland Å
    BMC Cancer; 2021 Oct; 21(1):1089. PubMed ID: 34625038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers.
    Luo W; Tian P; Wang Y; Xu H; Chen L; Tang C; Shu Y; Zhang S; Wang Z; Zhang J; Zhang L; Jiang L; Liu L; Che G; Guo C; Zhang H; Wang J; Li W
    Int J Cancer; 2018 Oct; 143(7):1696-1705. PubMed ID: 29667179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
    Aisner DL; Sholl LM; Berry LD; Rossi MR; Chen H; Fujimoto J; Moreira AL; Ramalingam SS; Villaruz LC; Otterson GA; Haura E; Politi K; Glisson B; Cetnar J; Garon EB; Schiller J; Waqar SN; Sequist LV; Brahmer J; Shyr Y; Kugler K; Wistuba II; Johnson BE; Minna JD; Kris MG; Bunn PA; Kwiatkowski DJ;
    Clin Cancer Res; 2018 Mar; 24(5):1038-1047. PubMed ID: 29217530
    [No Abstract]   [Full Text] [Related]  

  • 8. The evolution of non-small cell lung cancer metastases in TRACERx.
    Al Bakir M; Huebner A; Martínez-Ruiz C; Grigoriadis K; Watkins TBK; Pich O; Moore DA; Veeriah S; Ward S; Laycock J; Johnson D; Rowan A; Razaq M; Akther M; Naceur-Lombardelli C; Prymas P; Toncheva A; Hessey S; Dietzen M; Colliver E; Frankell AM; Bunkum A; Lim EL; Karasaki T; Abbosh C; Hiley CT; Hill MS; Cook DE; Wilson GA; Salgado R; Nye E; Stone RK; Fennell DA; Price G; Kerr KM; Naidu B; Middleton G; Summers Y; Lindsay CR; Blackhall FH; Cave J; Blyth KG; Nair A; Ahmed A; Taylor MN; Procter AJ; Falzon M; Lawrence D; Navani N; Thakrar RM; Janes SM; Papadatos-Pastos D; Forster MD; Lee SM; Ahmad T; Quezada SA; Peggs KS; Van Loo P; Dive C; Hackshaw A; Birkbak NJ; Zaccaria S; ; Jamal-Hanjani M; McGranahan N; Swanton C
    Nature; 2023 Apr; 616(7957):534-542. PubMed ID: 37046095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1.
    Liu J; Liu Y
    Pathol Res Pract; 2020 Feb; 216(2):152797. PubMed ID: 31926773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.
    Karasaki T; Moore DA; Veeriah S; Naceur-Lombardelli C; Toncheva A; Magno N; Ward S; Bakir MA; Watkins TBK; Grigoriadis K; Huebner A; Hill MS; Frankell AM; Abbosh C; Puttick C; Zhai H; Gimeno-Valiente F; Saghafinia S; Kanu N; Dietzen M; Pich O; Lim EL; Martínez-Ruiz C; Black JRM; Biswas D; Campbell BB; Lee C; Colliver E; Enfield KSS; Hessey S; Hiley CT; Zaccaria S; Litchfield K; Birkbak NJ; Cadieux EL; Demeulemeester J; Van Loo P; Adusumilli PS; Tan KS; Cheema W; Sanchez-Vega F; Jones DR; Rekhtman N; Travis WD; Hackshaw A; Marafioti T; Salgado R; Le Quesne J; Nicholson AG; ; McGranahan N; Swanton C; Jamal-Hanjani M
    Nat Med; 2023 Apr; 29(4):833-845. PubMed ID: 37045996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
    Zhao Y; Dong Y; Zhao R; Zhang B; Wang S; Zhang L; Hu M; He Q; Zhang W; Han B
    Clin Lung Cancer; 2020 Sep; 21(5):e355-e362. PubMed ID: 32139332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary trajectories of small cell lung cancer under therapy.
    George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
    Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
    Abbosh C; Frankell AM; Harrison T; Kisistok J; Garnett A; Johnson L; Veeriah S; Moreau M; Chesh A; Chaunzwa TL; Weiss J; Schroeder MR; Ward S; Grigoriadis K; Shahpurwalla A; Litchfield K; Puttick C; Biswas D; Karasaki T; Black JRM; Martínez-Ruiz C; Bakir MA; Pich O; Watkins TBK; Lim EL; Huebner A; Moore DA; Godin-Heymann N; L'Hernault A; Bye H; Odell A; Roberts P; Gomes F; Patel AJ; Manzano E; Hiley CT; Carey N; Riley J; Cook DE; Hodgson D; Stetson D; Barrett JC; Kortlever RM; Evan GI; Hackshaw A; Daber RD; Shaw JA; Aerts HJWL; Licon A; Stahl J; Jamal-Hanjani M; ; Birkbak NJ; McGranahan N; Swanton C
    Nature; 2023 Apr; 616(7957):553-562. PubMed ID: 37055640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.
    Selenica P; Marra A; Choudhury NJ; Gazzo A; Falcon CJ; Patel J; Pei X; Zhu Y; Ng CKY; Curry M; Heller G; Zhang YK; Berger MF; Ladanyi M; Rudin CM; Chandarlapaty S; Lovly CM; Reis-Filho JS; Yu HA
    Ann Oncol; 2022 Dec; 33(12):1284-1295. PubMed ID: 36089134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revealing the subtyping of non-small cell lung cancer based on genomic evolutionary patterns by multi-region sequencing.
    Liao G; Liang X; Ping Y; Zhang Y; Liao J; Wang Y; Hou X; Jiang Z; Dong X; Xu C; Xiao Y
    Cancer Med; 2020 Dec; 9(24):9485-9498. PubMed ID: 33078899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome.
    Grosse C; Soltermann A; Rechsteiner M; Grosse A
    PLoS One; 2019; 14(8):e0220691. PubMed ID: 31386689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
    Aggarwal A; Sharma S; Brar Z; Kumar V; Kumar A; Katara R; Mohanty SK
    Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.
    López S; Lim EL; Horswell S; Haase K; Huebner A; Dietzen M; Mourikis TP; Watkins TBK; Rowan A; Dewhurst SM; Birkbak NJ; Wilson GA; Van Loo P; Jamal-Hanjani M; ; Swanton C; McGranahan N
    Nat Genet; 2020 Mar; 52(3):283-293. PubMed ID: 32139907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma.
    Tang Z; Zhang J; Lu X; Wang W; Chen H; Robinson MK; Cheng J; Tang G; Medeiros LJ
    Mod Pathol; 2018 Feb; 31(2):307-312. PubMed ID: 28914263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking genomic cancer evolution for precision medicine: the lung TRACERx study.
    Jamal-Hanjani M; Hackshaw A; Ngai Y; Shaw J; Dive C; Quezada S; Middleton G; de Bruin E; Le Quesne J; Shafi S; Falzon M; Horswell S; Blackhall F; Khan I; Janes S; Nicolson M; Lawrence D; Forster M; Fennell D; Lee SM; Lester J; Kerr K; Muller S; Iles N; Smith S; Murugaesu N; Mitter R; Salm M; Stuart A; Matthews N; Adams H; Ahmad T; Attanoos R; Bennett J; Birkbak NJ; Booton R; Brady G; Buchan K; Capitano A; Chetty M; Cobbold M; Crosbie P; Davies H; Denison A; Djearman M; Goldman J; Haswell T; Joseph L; Kornaszewska M; Krebs M; Langman G; MacKenzie M; Millar J; Morgan B; Naidu B; Nonaka D; Peggs K; Pritchard C; Remmen H; Rowan A; Shah R; Smith E; Summers Y; Taylor M; Veeriah S; Waller D; Wilcox B; Wilcox M; Woolhouse I; McGranahan N; Swanton C
    PLoS Biol; 2014 Jul; 12(7):e1001906. PubMed ID: 25003521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.